Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models

Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models

Thumbnail Image
Download
Name

nihms-1761822.pdf

Description
Accepted version
Size

3.8 MB

Format

Adobe PDF

Checksum (MD5)

bb896a450e7761ebb2362a64ba3f3fab

sword-2023-04-04T17:45:07.original.xml (130 B)
Original SWORD entry document
Author(s)
Shim, Hong Seok
•
Horner, James W
•
Wu, Chang-Jiun
•
Li, Jiexi
•
Lan, Zheng D
•
Jiang, Shan
•
Xu, Xueping
•
Hsu, Wen-Hao
•
Zal, Tomasz
•
Flores, Ivonne I
more
Date Issued
2021
Journal
Nature Aging
Publisher
Springer Science and Business Media LLC
Citation
Shim, Hong Seok, Horner, James W, Wu, Chang-Jiun, Li, Jiexi, Lan, Zheng D et al. 2021. "Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models." Nature Aging, 1 (12).
Version
Author's final manuscript
Abstract
Amyloid-induced neurodegeneration plays a central role in Alzheimer's disease (AD) pathogenesis. Here, we show that telomerase reverse transcriptase (TERT) haploinsufficiency decreases BDNF and increases amyloid-β (Aβ) precursor in murine brain. Moreover, prior to disease onset, the TERT locus sustains accumulation of repressive epigenetic marks in murine and human AD neurons, implicating TERT repression in amyloid-induced neurodegeneration. To test the impact of sustained TERT expression on AD pathobiology, AD mouse models were engineered to maintain physiological levels of TERT in adult neurons, resulting in reduced Aβ accumulation, improved spine morphology, and preserved cognitive function. Mechanistically, integrated profiling revealed that TERT interacts with β-catenin and RNA polymerase II at gene promoters and upregulates gene networks governing synaptic signaling and learning processes. These TERT-directed transcriptional activities do not require its catalytic activity nor telomerase RNA. These findings provide genetic proof-of-concept for somatic TERT gene activation therapy in attenuating AD progression including cognitive decline.
MIT Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/150409
DOI of Published Version
https://doi.org/10.1038/S43587-021-00146-Z
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.